BREAST CANCER WITH NEUROENDOCRINE DIFFERENTIATION - THE CURRENT STATE OF KNOWLEDGE AND CLINICAL IMPLICATIONS
Background. Breast neuroendocrine neoplasms (BNETs) represent a rare and heterogeneous subgroup of breast cancers, comprising 2-5% of all breast carcinomas. Their classification has undergone significant changes following the WHO 2019 and 2022 revisions, which redefined diagnostic criteria and introduced new subtypes....